NCT01076361

Brief Summary

The Medtronic CapSure Epi Lead Post-approval Study will assess long-term safety of the 4968 lead. This study is part of the Medtronic System Longevity Study.

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
370

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 1999

Longer than P75 for all trials

Geographic Reach
12 countries

104 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 1999

Completed
10.5 years until next milestone

First Submitted

Initial submission to the registry

February 24, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 26, 2010

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
4.2 years until next milestone

Results Posted

Study results publicly available

October 27, 2014

Completed
Last Updated

October 27, 2014

Status Verified

October 1, 2014

Enrollment Period

11 years

First QC Date

February 24, 2010

Results QC Date

June 28, 2013

Last Update Submit

October 24, 2014

Conditions

Keywords

EpicardialPacing Lead

Outcome Measures

Primary Outcomes (1)

  • Survival Probability of the Model 4968 Lead Based on Lead-related Complications

    The survival analysis takes into account: Enrolled participants, lead follow-up time, and adjudicated lead related complications. The life-table method was used to analyze lead survival probability.

    The requirement to satisfy the PMA condition of Approval of model 4968 was to have 100 participants followed for a minimum of 5 years to assess the long-term safety.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects implanted with a 4968 lead.

You may qualify if:

  • Provision of written informed consent and/or authorization for access to and use of health information by subjects or appropriate legal guardians as required by an institution's Investigational Review Board, Medical Ethics Board, or Research Ethics Board
  • Availability of implant, follow-up, and product-related event data
  • Implanted with a Model 4968 Capsure Epi Lead

You may not qualify if:

  • Subjects receiving an implant of a Medtronic lead at a non-participating center and the implant data and current status cannot be confirmed within 30 days after implant
  • Subjects who are, or will be inaccessible for follow-up at a 4968 Post-approval study center
  • Subjects implanted with a Medtronic cardiac therapy device whose predetermined enrollment limit for that specific product has been exceeded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (106)

Alaska Heart Institute

Anchorage, Alaska, United States

Location

Unknown Facility

Gilbert, Arizona, United States

Location

Unknown Facility

Scottsdale, Arizona, United States

Location

Unknown Facility

Little Rock, Arkansas, United States

Location

Unknown Facility

Bakersville, California, United States

Location

Unknown Facility

Chula Vista, California, United States

Location

Unknown Facility

Downey, California, United States

Location

Unknown Facility

East Palo Alto, California, United States

Location

Unknown Facility

Los Angeles, California, United States

Location

Unknown Facility

Salinas, California, United States

Location

Unknown Facility

Torrance, California, United States

Location

Unknown Facility

Van Nuys, California, United States

Location

Unknown Facility

Colorado Springs, Colorado, United States

Location

Unknown Facility

Denver, Colorado, United States

Location

Unknown Facility

Washington D.C., District of Columbia, United States

Location

Unknown Facility

Clearwater, Florida, United States

Location

Unknown Facility

Jacksonville, Florida, United States

Location

Unknown Facility

Melbourne, Florida, United States

Location

Unknown Facility

Ocala, Florida, United States

Location

Unknown Facility

Wellington, Florida, United States

Location

Unknown Facility

Atlanta, Georgia, United States

Location

Unknown Facility

Columbus, Georgia, United States

Location

Unknown Facility

Marietta, Georgia, United States

Location

Unknown Facility

Oak Lawn, Illinois, United States

Location

Unknown Facility

Indianapolis, Indiana, United States

Location

Unknown Facility

Newburgh, Indiana, United States

Location

Unknown Facility

Des Moines, Iowa, United States

Location

Unknown Facility

Kansas City, Kansas, United States

Location

Unknown Facility

Lexington, Kentucky, United States

Location

Unknown Facility

Louisville, Kentucky, United States

Location

Unknown Facility

Alexandria, Louisiana, United States

Location

Unknown Facility

Baton Rouge, Louisiana, United States

Location

Unknown Facility

Salisbury, Maryland, United States

Location

Unknown Facility

Silver Spring, Maryland, United States

Location

Unknown Facility

Towson, Maryland, United States

Location

Unknown Facility

Grand Blanc, Michigan, United States

Location

Unknown Facility

Marquette, Michigan, United States

Location

Unknown Facility

Saginaw, Michigan, United States

Location

Unknown Facility

Southfield, Michigan, United States

Location

Unknown Facility

Robbinsdale, Minnesota, United States

Location

Unknown Facility

Rochester, Minnesota, United States

Location

Unknown Facility

Saint Paul, Minnesota, United States

Location

Unknown Facility

Kansas City, Missouri, United States

Location

Unknown Facility

Lebanon, New Hampshire, United States

Location

Unknown Facility

Browns Mills, New Jersey, United States

Location

Unknown Facility

Newark, New Jersey, United States

Location

Unknown Facility

Ocean City, New Jersey, United States

Location

Unknown Facility

Parlin, New Jersey, United States

Location

Unknown Facility

West Orange, New Jersey, United States

Location

Unknown Facility

Albuquerque, New Mexico, United States

Location

Unknown Facility

Mineola, New York, United States

Location

Unknown Facility

Rochester, New York, United States

Location

Unknown Facility

Greensboro, North Carolina, United States

Location

Unknown Facility

Hickory, North Carolina, United States

Location

Unknown Facility

Cincinnati, Ohio, United States

Location

Unknown Facility

Cleveland, Ohio, United States

Location

Unknown Facility

Columbus, Ohio, United States

Location

Unknown Facility

Toledo, Ohio, United States

Location

Unknown Facility

Portland, Oregon, United States

Location

Unknown Facility

Doylestown, Pennsylvania, United States

Location

Unknown Facility

Lancaster, Pennsylvania, United States

Location

Unknown Facility

Sayre, Pennsylvania, United States

Location

Unknown Facility

Columbia, South Carolina, United States

Location

Unknown Facility

Florence, South Carolina, United States

Location

Unknown Facility

Sioux Falls, South Dakota, United States

Location

Unknown Facility

Chattanooga, Tennessee, United States

Location

Unknown Facility

Germantown, Tennessee, United States

Location

Unknown Facility

Memphis, Tennessee, United States

Location

Unknown Facility

Nashville, Tennessee, United States

Location

Unknown Facility

Amarillo, Texas, United States

Location

Unknown Facility

Austin, Texas, United States

Location

Unknown Facility

Dallas, Texas, United States

Location

Unknown Facility

Fort Worth, Texas, United States

Location

Unknown Facility

Houston, Texas, United States

Location

Unknown Facility

San Antonio, Texas, United States

Location

Unknown Facility

The Woodlands, Texas, United States

Location

Unknown Facility

Burlington, Vermont, United States

Location

Unknown Facility

Chesapeake, Virginia, United States

Location

Unknown Facility

Fairfax, Virginia, United States

Location

Unknown Facility

Olympia, Washington, United States

Location

Unknown Facility

Spokane, Washington, United States

Location

Unknown Facility

Madison, Wisconsin, United States

Location

Unknown Facility

Milwaukee, Wisconsin, United States

Location

Unknown Facility

Bedford Park, South Australia, Australia

Location

Unknown Facility

Linz, Austria

Location

Unknown Facility

Vienna, Austria

Location

Unknown Facility

Hasselt, Belgium

Location

Unknown Facility

Calgary, Alberta, Canada

Location

Unknown Facility

Hamilton, Ontario, Canada

Location

Unknown Facility

Ottawa, Ontario, Canada

Location

Unknown Facility

Toronto, Ontario, Canada

Location

Unknown Facility

Montreal, Quebec, Canada

Location

Unknown Facility

Ste-Foy, Quebec, Canada

Location

Unknown Facility

Regina, Saskatchewan, Canada

Location

Unknown Facility

Copenhagen, Denmark

Location

Unknown Facility

Marseille, France

Location

Unknown Facility

Homburg/Saar, Germany

Location

Unknown Facility

Catanzaro, Italy

Location

Unknown Facility

Reggio Emilia, Italy

Location

Unknown Facility

Udine, Italy

Location

Unknown Facility

Eindhoven, Netherlands

Location

Unknown Facility

Rotterdam, Netherlands

Location

Unknown Facility

Belgrade, Serbia and Montenegro

Location

Unknown Facility

Valencia, Spain

Location

Unknown Facility

Skövde, Sweden

Location

Unknown Facility

Zurich, Switzerland

Location

MeSH Terms

Conditions

Arrhythmias, CardiacHeart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
4968 Clinical Trial Leader
Organization
Medtronic

Study Officials

  • 4968 Clinical Trial Leader

    Medtronic

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2010

First Posted

February 26, 2010

Study Start

September 1, 1999

Primary Completion

September 1, 2010

Study Completion

September 1, 2010

Last Updated

October 27, 2014

Results First Posted

October 27, 2014

Record last verified: 2014-10

Locations